INFLUENCE OF HEMOGLOBIN IN DETECTION OF BLADDER CANCER BY USING UBC RAPID, NMP22 BLADDERCHEK AND BTA STAT

被引：0
|
作者：
Luedecke, G. [1 ]
Pilatz, A. [1 ]
Hauptmann, A. [1 ]
Bschleipfer, Th. [1 ]
Weidner, W. [1 ]
机构：
[1] Univ Clin Giessen & Marburg, Clin & Policlin Urol Pediat Urol & Androl, Giessen, Germany
来源：
ANTICANCER RESEARCH | 2011年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1991 / 1991
页数：1
相关论文
共 50 条
  • [1] Comparison of BTA stat and NMP22 tests in the detection of bladder cancer
    Öge, Ö
    Atsü, N
    Sahin, A
    Özen, H
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 (06): : 349 - 351
  • [2] Effect of hematuria on the performance of BTA stat®, UBC® rapid test and NMP22® as urine-based biomarker for bladder cancer detection
    Weiss, S.
    Meisl, C. J.
    Schlomm, T.
    Rabien, A.
    Rong, D.
    Hofbauer, S.
    Friedersdorff, F.
    Sommerfeld, L.
    Gagel, N.
    Barski, D.
    Otto, T.
    Grunewald, C. M.
    Niegisch, G.
    Kramer, M. W.
    Koch, S.
    Linden, F.
    Hake, R.
    Wirtz, R. M.
    Eidt, S.
    Waldner, M.
    Graff, J.
    Jagarlamudi, K.
    Hallmann, S.
    Ecke, T. H.
    EUROPEAN UROLOGY, 2024, 85 : S400 - S401
  • [3] The value of urinary based rapid tests during follow-up in bladder cancer: BTA stat®, Alere NMP22® BladderChek®, UBC® rapid test, CancerCheck® UBC® rapid VISUAL, and uromonitor® in comparison to cytology
    Ecke, T. H.
    Meisl, C. J.
    Hofbauer, S.
    Labonte, F.
    Schlomm, T.
    Rong, D.
    Rabien, A.
    Friedersdorff, F.
    Sommerfeldt, L.
    Gagel, N.
    Goessl, A.
    Barski, D.
    Otto, T.
    Grunewald, C. M.
    Niegisch, G.
    Hennig, M. J. P.
    Kramer, M. W.
    Waldner, M.
    Koch, S.
    Hallmann, S.
    Veltrup, E.
    Linden, F.
    Wirtz, R.
    EUROPEAN UROLOGY, 2023, 83 : S868 - S868
  • [4] BTA stat®, Alere NMP22® BladderChek®, UBC® rapid test, and CancerCheck® UBC® rapid VISUAL in comparison to cytology as tumor marker for urinary bladder cancer: Final results of a German multicentre-study
    Ecke, T. H.
    Meisl, C. J.
    Hofbauer, S.
    Labonte, F.
    Schlomm, T.
    Rong, D.
    Rabien, A.
    Friedersdorff, F.
    Sommerfeldt, L.
    Gagel, N.
    Goessl, A.
    Barski, D.
    Otto, T.
    Grunewald, C. M.
    Niegisch, G.
    Hennig, M. J. P.
    Kramer, M.
    Koch, S.
    Hallmann, S.
    Waldner, M.
    Veltrup, E.
    Linden, F.
    Wirtz, R. M.
    EUROPEAN UROLOGY, 2023, 83 : S390 - S390
  • [5] BTA stat®, Alere NMP22® BladderChek®, UBC® rapid test, and uromonitor® in comparison to cytology as tumor marker for urinary bladder cancer: New results of a german multicentre-study
    Ecke, T. H.
    Meisl, C.
    Hofbauer, S.
    Labonte, F.
    Schlomm, T.
    Friedersdorff, F.
    Goessl, A.
    Barski, D.
    Otto, T.
    Grunewald, C.
    Niegisch, G.
    Hennig, M.
    Kramer, M.
    Koch, S.
    Hallmann, S.
    EUROPEAN UROLOGY, 2022, 81 : S115 - S115
  • [6] Usefulness of NMP22 BladderChek for the diagnosis and monitoring of bladder cancer
    Seo, Soyeon
    Cho, Sungeun
    Hong, Kisook
    Shim, Bongsuk
    Kwon, Sungwon
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2007, 27 (01): : 22 - 27
  • [7] Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer
    Kumar, A
    Kumar, R
    Gupta, NP
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (03) : 172 - 175
  • [8] Urinary NMP22® BladderChek® test in the diagnosis of superficial bladder cancer
    Moonen, PMJ
    Kiemeney, LALM
    Witjes, JA
    EUROPEAN UROLOGY, 2005, 48 (06) : 951 - 956
  • [9] Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology
    Ecke, Thorsten H.
    Meisl, Christina J.
    Schlomm, Thorsten
    Rabien, Anja
    Labonte, Flora
    Rong, Dezhi
    Hofbauer, Sebastian
    Friedersdorff, Frank
    Sommerfeldt, Lilli
    Gagel, Nella
    Goessl, Andreas
    Barski, Dimitri
    Otto, Thomas
    Grunewald, Camilla M.
    Niegisch, Guenter
    Hennig, Martin J. P.
    Kramer, Mario W.
    Koch, Stefan
    Roggisch, Jenny
    Weiss, Sarah
    Waldner, Michael
    Graff, Johannes
    Veltrup, Elke
    Linden, Friederike
    Hake, Roland
    Eidt, Sebastian
    Wirtz, Ralph M.
    Klatte, Tobias
    UROLOGY, 2025, 197 : 119 - 125
  • [10] Bladder cancer screening in a high risk asymptomatic population using the NMP22 BladderChek test
    Lotan, Yair
    Svatek, Robert
    Elias, Keren
    Moran, Brett
    Sagalowsky, Arthur
    CANCER RESEARCH, 2008, 68 (09)
12345